Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
reg-snw-56655 | wolf-screen-ratio-mammosphere-adherent | 0.828 | 9.29e-07 | 2.91e-03 | 5.53e-03 | 8 | 7 |
int-snw-10393 | wolf-screen-ratio-mammosphere-adherent | 0.971 | 6.41e-17 | 1.11e-03 | 2.23e-02 | 12 | 12 |
reg-snw-5925 | wolf-screen-ratio-mammosphere-adherent | 0.802 | 2.42e-06 | 4.82e-03 | 8.69e-03 | 8 | 5 |
Gene Symbol | Entrez Gene ID | Frequency | wolf-screen-ratio-mammosphere-adherent gene score | Best subnetwork score | Degree | wolf adherent-list Hits GI | wolf mammosphere no adherent-list Hits GI |
---|---|---|---|---|---|---|---|
PPCS | 79717 | 31 | -0.569 | 0.802 | 2 | - | Yes |
UBA1 | 7317 | 6 | 0.555 | 0.971 | 207 | Yes | - |
PSMA2 | 5683 | 112 | 1.093 | 1.106 | 108 | Yes | - |
RBX1 | 9978 | 115 | 1.185 | 0.934 | 148 | Yes | - |
PPIE | 10450 | 31 | 0.567 | 0.802 | 41 | - | - |
PSMB7 | 5695 | 118 | 0.982 | 0.934 | 90 | Yes | - |
VARS | 7407 | 86 | 0.549 | 1.002 | 204 | Yes | - |
OGDH | 4967 | 72 | 0.847 | 0.802 | 126 | Yes | - |
POLE4 | 56655 | 63 | 0.177 | 0.828 | 56 | - | - |
TFRC | 7037 | 31 | 0.730 | 0.802 | 17 | - | - |
RPSA | 3921 | 120 | 1.327 | 1.151 | 152 | Yes | - |
PSMB3 | 5691 | 64 | 0.668 | 0.901 | 19 | Yes | - |
PGD | 5226 | 89 | 1.201 | 1.106 | 152 | Yes | - |
RPA2 | 6118 | 96 | 1.250 | 1.151 | 76 | Yes | - |
RB1 | 5925 | 31 | -0.102 | 0.802 | 351 | - | - |
ACO2 | 50 | 65 | 1.000 | 1.076 | 191 | Yes | - |
CDC16 | 8881 | 53 | 0.950 | 1.020 | 80 | Yes | - |
PPP2R1A | 5518 | 19 | 0.644 | 0.985 | 249 | Yes | - |
ANAPC10 | 10393 | 3 | 0.195 | 0.971 | 46 | Yes | - |
PSMB2 | 5690 | 116 | 0.877 | 0.956 | 169 | Yes | - |
PSMD11 | 5717 | 124 | 1.095 | 1.106 | 218 | Yes | - |
ACTB | 60 | 134 | 1.153 | 1.151 | 610 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
PPP2R1A | 5518 | PSMB3 | 5691 | pp | -- | int.I2D: IntAct_Mouse |
ACO2 | 50 | OGDH | 4967 | pp | -- | int.I2D: YeastLow |
RB1 | 5925 | PPCS | 79717 | pd | > | reg.pazar.txt: no annot |
RB1 | 5925 | RPA2 | 6118 | pd | > | reg.pazar.txt: no annot |
PSMA2 | 5683 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BCI, BioGrid, BioGrid_Yeast, BIND_Yeast, IntAct, Krogan_Core, MINT_Yeast, YeastLow, IntAct_Yeast |
ACO2 | 50 | UBA1 | 7317 | pp | -- | int.I2D: YeastLow |
PSMB2 | 5690 | POLE4 | 56655 | pd | < | reg.ITFP.txt: no annot |
PSMA2 | 5683 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
RPSA | 3921 | PSMD11 | 5717 | pp | -- | int.I2D: IntAct_Yeast |
PGD | 5226 | RB1 | 5925 | pd | < | reg.pazar.txt: no annot |
ACO2 | 50 | PSMD11 | 5717 | pp | -- | int.I2D: YeastLow |
ACTB | 60 | PSMB2 | 5690 | pp | -- | int.I2D: BioGrid_Yeast |
RBX1 | 9978 | PPIE | 10450 | pd | <> | reg.ITFP.txt: no annot |
PPP2R1A | 5518 | ANAPC10 | 10393 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
RPSA | 3921 | VARS | 7407 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | RBX1 | 9978 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | ANAPC10 | 10393 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastLow |
ACTB | 60 | RPSA | 3921 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct_Yeast, IntAct |
OGDH | 4967 | RB1 | 5925 | pd | < | reg.ITFP.txt: no annot |
PPP2R1A | 5518 | PSMB2 | 5690 | pp | -- | int.I2D: IntAct_Mouse |
ACTB | 60 | PPP2R1A | 5518 | pp | -- | int.I2D: BioGrid_Yeast |
OGDH | 4967 | PGD | 5226 | pp | -- | int.I2D: YeastLow |
PGD | 5226 | UBA1 | 7317 | pp | -- | int.I2D: YeastLow |
PSMB7 | 5695 | RBX1 | 9978 | pd | < | reg.ITFP.txt: no annot |
PGD | 5226 | PSMD11 | 5717 | pp | -- | int.I2D: YeastLow |
VARS | 7407 | POLE4 | 56655 | pd | <> | reg.ITFP.txt: no annot |
PSMA2 | 5683 | PSMB3 | 5691 | pp | -- | int.Intact: MI:0914(association); int.I2D: BCI, BioGrid, BioGrid_Yeast, BIND_Yeast, IntAct, IntAct_Fly, IntAct_Yeast, INTEROLOG, Krogan_Core, MINT_Yeast, YeastHigh, Yu_GoldStd |
PPP2R1A | 5518 | PSMB7 | 5695 | pp | -- | int.I2D: IntAct_Mouse |
PSMB7 | 5695 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | RB1 | 5925 | pd | < | reg.ITFP.txt: no annot |
PSMA2 | 5683 | POLE4 | 56655 | pd | < | reg.ITFP.txt: no annot |
ACTB | 60 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB7 | 5695 | POLE4 | 56655 | pd | < | reg.ITFP.txt: no annot |
PSMB2 | 5690 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, Krogan_Core, MINT_Yeast, YeastLow, IntAct |
PSMB3 | 5691 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BCI, BioGrid_Yeast, BIND_Yeast, IntAct, IntAct_Yeast, YeastHigh, HPRD, Krogan_Core, MINT_Yeast, MIPS; int.HPRD: yeast 2-hybrid |
PGD | 5226 | PPP2R1A | 5518 | pp | -- | int.I2D: YeastLow |
ACTB | 60 | PSMB7 | 5695 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB2 | 5690 | PSMB3 | 5691 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, INTEROLOG, MINT, Yu_GoldStd, BCI, BioGrid_Yeast, BIND_Yeast, HPRD, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
ACTB | 60 | RPA2 | 6118 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
ACO2 | 50 | PGD | 5226 | pp | -- | int.I2D: YeastLow |
ACTB | 60 | CDC16 | 8881 | pp | -- | int.I2D: YeastLow |
OGDH | 4967 | PSMD11 | 5717 | pp | -- | int.I2D: YeastLow |
UBA1 | 7317 | VARS | 7407 | pp | -- | int.I2D: Krogan_NonCore, YeastLow |
PSMB3 | 5691 | POLE4 | 56655 | pd | < | reg.ITFP.txt: no annot |
PSMB7 | 5695 | PPIE | 10450 | pd | < | reg.ITFP.txt: no annot |
PPP2R1A | 5518 | PSMA2 | 5683 | pp | -- | int.I2D: IntAct_Mouse |
RB1 | 5925 | TFRC | 7037 | pd | > | reg.ITFP.txt: no annot |
PSMB2 | 5690 | PSMD11 | 5717 | pd | < | reg.ITFP.txt: no annot |
PSMB2 | 5690 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
PSMB2 | 5690 | VARS | 7407 | pd | < | reg.ITFP.txt: no annot |
CDC16 | 8881 | ANAPC10 | 10393 | pp | -- | int.Intact: MI:0915(physical association), MI:0914(association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Yeast, BIND_Yeast, HPRD, Krogan_Core, MINT_Yeast, MIPS, YeastLow; int.HPRD: in vivo |
PPP2R1A | 5518 | UBA1 | 7317 | pp | -- | int.I2D: IntAct_Yeast, YeastLow |
UBA1 | 7317 | ANAPC10 | 10393 | pp | -- | int.I2D: IntAct_Yeast |
PSMB3 | 5691 | PSMD11 | 5717 | pp | -- | int.I2D: YeastLow |
RB1 | 5925 | PPIE | 10450 | pd | > | reg.pazar.txt: no annot |
PSMA2 | 5683 | PSMB2 | 5690 | pp | -- | int.Intact: MI:0914(association); int.I2D: BCI, BioGrid, BioGrid_Yeast, IntAct, INTEROLOG, MINT_Yeast, YeastHigh, IntAct_Yeast, Krogan_Core |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.85e-12 | 3.03e-08 | 6.320 | 7 | 24 | 65 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.18e-12 | 5.19e-08 | 6.213 | 7 | 24 | 70 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.76e-12 | 7.76e-08 | 6.133 | 7 | 24 | 74 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 7.63e-12 | 1.25e-07 | 6.039 | 7 | 25 | 79 |
GO:0000278 | mitotic cell cycle | 3.31e-11 | 5.40e-07 | 4.220 | 10 | 52 | 398 |
GO:0000082 | G1/S transition of mitotic cell cycle | 7.31e-10 | 1.19e-05 | 5.114 | 7 | 33 | 150 |
GO:0006521 | regulation of cellular amino acid metabolic process | 5.56e-09 | 9.08e-05 | 6.213 | 5 | 21 | 50 |
GO:0005839 | proteasome core complex | 7.48e-09 | 1.22e-04 | 7.365 | 4 | 11 | 18 |
GO:0016071 | mRNA metabolic process | 1.16e-08 | 1.89e-04 | 4.541 | 7 | 34 | 223 |
GO:0004298 | threonine-type endopeptidase activity | 1.18e-08 | 1.93e-04 | 7.213 | 4 | 11 | 20 |
GO:0000502 | proteasome complex | 1.19e-08 | 1.95e-04 | 5.999 | 5 | 22 | 58 |
GO:0016032 | viral process | 1.51e-08 | 2.46e-04 | 3.628 | 9 | 55 | 540 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2.14e-08 | 3.49e-04 | 5.835 | 5 | 22 | 65 |
GO:0016070 | RNA metabolic process | 2.35e-08 | 3.83e-04 | 4.394 | 7 | 34 | 247 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 3.87e-08 | 6.31e-04 | 5.667 | 5 | 23 | 73 |
GO:0005654 | nucleoplasm | 4.19e-08 | 6.83e-04 | 2.898 | 11 | 83 | 1095 |
GO:0005829 | cytosol | 4.72e-08 | 7.70e-04 | 2.119 | 15 | 125 | 2562 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 5.07e-08 | 8.27e-04 | 5.590 | 5 | 23 | 77 |
GO:0034641 | cellular nitrogen compound metabolic process | 9.65e-08 | 1.58e-03 | 4.652 | 6 | 25 | 177 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.39e-07 | 2.26e-03 | 5.302 | 5 | 23 | 94 |
GO:0000209 | protein polyubiquitination | 3.98e-07 | 6.49e-03 | 4.999 | 5 | 21 | 116 |
GO:0010467 | gene expression | 1.47e-06 | 2.39e-02 | 3.149 | 8 | 58 | 669 |
GO:0042981 | regulation of apoptotic process | 1.47e-06 | 2.40e-02 | 4.619 | 5 | 26 | 151 |
GO:0044281 | small molecule metabolic process | 2.33e-05 | 3.81e-01 | 2.366 | 9 | 57 | 1295 |
GO:0070062 | extracellular vesicular exosome | 2.49e-05 | 4.06e-01 | 1.823 | 12 | 98 | 2516 |
GO:0006915 | apoptotic process | 8.25e-05 | 1.00e+00 | 2.963 | 6 | 34 | 571 |
GO:0043066 | negative regulation of apoptotic process | 2.33e-04 | 1.00e+00 | 3.099 | 5 | 30 | 433 |
GO:0005680 | anaphase-promoting complex | 3.25e-04 | 1.00e+00 | 6.213 | 2 | 4 | 20 |
GO:0070979 | protein K11-linked ubiquitination | 5.53e-04 | 1.00e+00 | 5.835 | 2 | 3 | 26 |
GO:0006099 | tricarboxylic acid cycle | 6.89e-04 | 1.00e+00 | 5.677 | 2 | 3 | 29 |
GO:0007094 | mitotic spindle assembly checkpoint | 7.88e-04 | 1.00e+00 | 5.581 | 2 | 5 | 31 |
GO:0005515 | protein binding | 8.57e-04 | 1.00e+00 | 0.954 | 16 | 172 | 6127 |
GO:0005634 | nucleus | 9.59e-04 | 1.00e+00 | 1.105 | 14 | 131 | 4828 |
GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity | 1.35e-03 | 1.00e+00 | 9.535 | 1 | 1 | 1 |
GO:0090230 | regulation of centromere complex assembly | 1.35e-03 | 1.00e+00 | 9.535 | 1 | 1 | 1 |
GO:0070262 | peptidyl-serine dephosphorylation | 1.35e-03 | 1.00e+00 | 9.535 | 1 | 1 | 1 |
GO:0004632 | phosphopantothenate--cysteine ligase activity | 1.35e-03 | 1.00e+00 | 9.535 | 1 | 1 | 1 |
GO:0019521 | D-gluconate metabolic process | 1.35e-03 | 1.00e+00 | 9.535 | 1 | 1 | 1 |
GO:0031625 | ubiquitin protein ligase binding | 1.74e-03 | 1.00e+00 | 3.628 | 3 | 13 | 180 |
GO:0005739 | mitochondrion | 2.09e-03 | 1.00e+00 | 2.089 | 6 | 24 | 1046 |
GO:0006091 | generation of precursor metabolites and energy | 2.12e-03 | 1.00e+00 | 4.863 | 2 | 3 | 51 |
GO:0004832 | valine-tRNA ligase activity | 2.69e-03 | 1.00e+00 | 8.535 | 1 | 1 | 2 |
GO:0045252 | oxoglutarate dehydrogenase complex | 2.69e-03 | 1.00e+00 | 8.535 | 1 | 2 | 2 |
GO:0051538 | 3 iron, 4 sulfur cluster binding | 2.69e-03 | 1.00e+00 | 8.535 | 1 | 1 | 2 |
GO:0003994 | aconitate hydratase activity | 2.69e-03 | 1.00e+00 | 8.535 | 1 | 1 | 2 |
GO:0097286 | iron ion import | 2.69e-03 | 1.00e+00 | 8.535 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 2.69e-03 | 1.00e+00 | 8.535 | 1 | 1 | 2 |
GO:0006438 | valyl-tRNA aminoacylation | 2.69e-03 | 1.00e+00 | 8.535 | 1 | 1 | 2 |
GO:0061034 | olfactory bulb mitral cell layer development | 2.69e-03 | 1.00e+00 | 8.535 | 1 | 1 | 2 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.69e-03 | 1.00e+00 | 8.535 | 1 | 1 | 2 |
GO:0004998 | transferrin receptor activity | 2.69e-03 | 1.00e+00 | 8.535 | 1 | 1 | 2 |
GO:0019322 | pentose biosynthetic process | 2.69e-03 | 1.00e+00 | 8.535 | 1 | 1 | 2 |
GO:0031134 | sister chromatid biorientation | 2.69e-03 | 1.00e+00 | 8.535 | 1 | 1 | 2 |
GO:0005055 | laminin receptor activity | 2.69e-03 | 1.00e+00 | 8.535 | 1 | 1 | 2 |
GO:0007070 | negative regulation of transcription from RNA polymerase II promoter during mitosis | 2.69e-03 | 1.00e+00 | 8.535 | 1 | 2 | 2 |
GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 3 |
GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 3 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 3 |
GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 3 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 5.38e-03 | 1.00e+00 | 7.535 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 5.38e-03 | 1.00e+00 | 7.535 | 1 | 1 | 4 |
GO:0071922 | regulation of cohesin localization to chromatin | 5.38e-03 | 1.00e+00 | 7.535 | 1 | 1 | 4 |
GO:0019788 | NEDD8 ligase activity | 5.38e-03 | 1.00e+00 | 7.535 | 1 | 1 | 4 |
GO:0006104 | succinyl-CoA metabolic process | 5.38e-03 | 1.00e+00 | 7.535 | 1 | 1 | 4 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 5.38e-03 | 1.00e+00 | 7.535 | 1 | 1 | 4 |
GO:0043550 | regulation of lipid kinase activity | 5.38e-03 | 1.00e+00 | 7.535 | 1 | 1 | 4 |
GO:0004839 | ubiquitin activating enzyme activity | 5.38e-03 | 1.00e+00 | 7.535 | 1 | 1 | 4 |
GO:0035189 | Rb-E2F complex | 5.38e-03 | 1.00e+00 | 7.535 | 1 | 1 | 4 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 5.38e-03 | 1.00e+00 | 7.535 | 1 | 1 | 4 |
GO:0034349 | glial cell apoptotic process | 5.38e-03 | 1.00e+00 | 7.535 | 1 | 1 | 4 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 6.72e-03 | 1.00e+00 | 7.213 | 1 | 2 | 5 |
GO:0019932 | second-messenger-mediated signaling | 6.72e-03 | 1.00e+00 | 7.213 | 1 | 1 | 5 |
GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein | 6.72e-03 | 1.00e+00 | 7.213 | 1 | 1 | 5 |
GO:2000001 | regulation of DNA damage checkpoint | 6.72e-03 | 1.00e+00 | 7.213 | 1 | 1 | 5 |
GO:0008622 | epsilon DNA polymerase complex | 6.72e-03 | 1.00e+00 | 7.213 | 1 | 1 | 5 |
GO:0019941 | modification-dependent protein catabolic process | 6.72e-03 | 1.00e+00 | 7.213 | 1 | 1 | 5 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 6.72e-03 | 1.00e+00 | 7.213 | 1 | 1 | 5 |
GO:0043248 | proteasome assembly | 6.72e-03 | 1.00e+00 | 7.213 | 1 | 1 | 5 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 6.72e-03 | 1.00e+00 | 7.213 | 1 | 1 | 5 |
GO:0006102 | isocitrate metabolic process | 6.72e-03 | 1.00e+00 | 7.213 | 1 | 1 | 5 |
GO:0030891 | VCB complex | 6.72e-03 | 1.00e+00 | 7.213 | 1 | 2 | 5 |
GO:0000730 | DNA recombinase assembly | 6.72e-03 | 1.00e+00 | 7.213 | 1 | 3 | 5 |
GO:0006734 | NADH metabolic process | 6.72e-03 | 1.00e+00 | 7.213 | 1 | 1 | 5 |
GO:0030976 | thiamine pyrophosphate binding | 6.72e-03 | 1.00e+00 | 7.213 | 1 | 1 | 5 |
GO:0016605 | PML body | 6.75e-03 | 1.00e+00 | 4.011 | 2 | 5 | 92 |
GO:0043353 | enucleate erythrocyte differentiation | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 6 |
GO:0009108 | coenzyme biosynthetic process | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 6 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 6 |
GO:0006101 | citrate metabolic process | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 6 |
GO:0021860 | pyramidal neuron development | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 6 |
GO:0031466 | Cul5-RING ubiquitin ligase complex | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 6 |
GO:0021695 | cerebellar cortex development | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 6 |
GO:0030957 | Tat protein binding | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 4 | 6 |
GO:0000028 | ribosomal small subunit assembly | 9.40e-03 | 1.00e+00 | 6.728 | 1 | 1 | 7 |
GO:0002161 | aminoacyl-tRNA editing activity | 9.40e-03 | 1.00e+00 | 6.728 | 1 | 2 | 7 |
GO:0031462 | Cul2-RING ubiquitin ligase complex | 9.40e-03 | 1.00e+00 | 6.728 | 1 | 2 | 7 |
GO:0030867 | rough endoplasmic reticulum membrane | 9.40e-03 | 1.00e+00 | 6.728 | 1 | 1 | 7 |
GO:0016018 | cyclosporin A binding | 9.40e-03 | 1.00e+00 | 6.728 | 1 | 1 | 7 |
GO:0015630 | microtubule cytoskeleton | 9.86e-03 | 1.00e+00 | 3.728 | 2 | 5 | 112 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.02e-02 | 1.00e+00 | 3.702 | 2 | 10 | 114 |
GO:0005819 | spindle | 1.02e-02 | 1.00e+00 | 3.702 | 2 | 7 | 114 |
GO:0072562 | blood microparticle | 1.05e-02 | 1.00e+00 | 3.677 | 2 | 4 | 116 |
GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 1.07e-02 | 1.00e+00 | 6.535 | 1 | 2 | 8 |
GO:0070688 | MLL5-L complex | 1.07e-02 | 1.00e+00 | 6.535 | 1 | 1 | 8 |
GO:0006554 | lysine catabolic process | 1.07e-02 | 1.00e+00 | 6.535 | 1 | 2 | 8 |
GO:0045116 | protein neddylation | 1.07e-02 | 1.00e+00 | 6.535 | 1 | 2 | 8 |
GO:0019773 | proteasome core complex, alpha-subunit complex | 1.07e-02 | 1.00e+00 | 6.535 | 1 | 5 | 8 |
GO:0044237 | cellular metabolic process | 1.09e-02 | 1.00e+00 | 3.652 | 2 | 3 | 118 |
GO:0015937 | coenzyme A biosynthetic process | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 1 | 9 |
GO:0097284 | hepatocyte apoptotic process | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 2 | 9 |
GO:0000075 | cell cycle checkpoint | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 2 | 9 |
GO:0006450 | regulation of translational fidelity | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 2 | 10 |
GO:0007084 | mitotic nuclear envelope reassembly | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 10 |
GO:0015939 | pantothenate metabolic process | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 10 |
GO:0021756 | striatum development | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 10 |
GO:0006098 | pentose-phosphate shunt | 1.47e-02 | 1.00e+00 | 6.076 | 1 | 3 | 11 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 1.47e-02 | 1.00e+00 | 6.076 | 1 | 1 | 11 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 1.47e-02 | 1.00e+00 | 6.076 | 1 | 3 | 11 |
GO:0042551 | neuron maturation | 1.47e-02 | 1.00e+00 | 6.076 | 1 | 2 | 11 |
GO:0045651 | positive regulation of macrophage differentiation | 1.47e-02 | 1.00e+00 | 6.076 | 1 | 2 | 11 |
GO:0051146 | striated muscle cell differentiation | 1.61e-02 | 1.00e+00 | 5.950 | 1 | 1 | 12 |
GO:0006275 | regulation of DNA replication | 1.61e-02 | 1.00e+00 | 5.950 | 1 | 2 | 12 |
GO:0021794 | thalamus development | 1.61e-02 | 1.00e+00 | 5.950 | 1 | 1 | 12 |
GO:0030111 | regulation of Wnt signaling pathway | 1.61e-02 | 1.00e+00 | 5.950 | 1 | 1 | 12 |
GO:0005838 | proteasome regulatory particle | 1.61e-02 | 1.00e+00 | 5.950 | 1 | 7 | 12 |
GO:0006457 | protein folding | 1.70e-02 | 1.00e+00 | 3.316 | 2 | 8 | 149 |
GO:0005662 | DNA replication factor A complex | 1.74e-02 | 1.00e+00 | 5.835 | 1 | 3 | 13 |
GO:0045780 | positive regulation of bone resorption | 1.74e-02 | 1.00e+00 | 5.835 | 1 | 1 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.87e-02 | 1.00e+00 | 5.728 | 1 | 4 | 14 |
GO:0006672 | ceramide metabolic process | 2.00e-02 | 1.00e+00 | 5.628 | 1 | 1 | 15 |
GO:0045445 | myoblast differentiation | 2.00e-02 | 1.00e+00 | 5.628 | 1 | 2 | 15 |
GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand | 2.00e-02 | 1.00e+00 | 5.628 | 1 | 2 | 15 |
GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex | 2.00e-02 | 1.00e+00 | 5.628 | 1 | 1 | 15 |
GO:0016514 | SWI/SNF complex | 2.00e-02 | 1.00e+00 | 5.628 | 1 | 3 | 15 |
GO:0050998 | nitric-oxide synthase binding | 2.14e-02 | 1.00e+00 | 5.535 | 1 | 1 | 16 |
GO:0006103 | 2-oxoglutarate metabolic process | 2.14e-02 | 1.00e+00 | 5.535 | 1 | 1 | 16 |
GO:0010243 | response to organonitrogen compound | 2.27e-02 | 1.00e+00 | 5.448 | 1 | 2 | 17 |
GO:0045070 | positive regulation of viral genome replication | 2.27e-02 | 1.00e+00 | 5.448 | 1 | 1 | 17 |
GO:0022624 | proteasome accessory complex | 2.27e-02 | 1.00e+00 | 5.448 | 1 | 9 | 17 |
GO:0035861 | site of double-strand break | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 18 |
GO:0016020 | membrane | 2.46e-02 | 1.00e+00 | 1.350 | 6 | 80 | 1746 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.53e-02 | 1.00e+00 | 5.287 | 1 | 1 | 19 |
GO:0048863 | stem cell differentiation | 2.53e-02 | 1.00e+00 | 5.287 | 1 | 1 | 19 |
GO:0007088 | regulation of mitosis | 2.53e-02 | 1.00e+00 | 5.287 | 1 | 1 | 19 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 2.66e-02 | 1.00e+00 | 5.213 | 1 | 2 | 20 |
GO:0008601 | protein phosphatase type 2A regulator activity | 2.66e-02 | 1.00e+00 | 5.213 | 1 | 3 | 20 |
GO:0006298 | mismatch repair | 2.66e-02 | 1.00e+00 | 5.213 | 1 | 6 | 20 |
GO:0000159 | protein phosphatase type 2A complex | 2.66e-02 | 1.00e+00 | 5.213 | 1 | 2 | 20 |
GO:0045595 | regulation of cell differentiation | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 1 | 21 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 5 | 21 |
GO:0030316 | osteoclast differentiation | 2.93e-02 | 1.00e+00 | 5.076 | 1 | 2 | 22 |
GO:0000792 | heterochromatin | 2.93e-02 | 1.00e+00 | 5.076 | 1 | 2 | 22 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 2.93e-02 | 1.00e+00 | 5.076 | 1 | 5 | 22 |
GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 2.93e-02 | 1.00e+00 | 5.076 | 1 | 3 | 22 |
GO:0032201 | telomere maintenance via semi-conservative replication | 2.93e-02 | 1.00e+00 | 5.076 | 1 | 7 | 22 |
GO:0030863 | cortical cytoskeleton | 2.93e-02 | 1.00e+00 | 5.076 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.93e-02 | 1.00e+00 | 5.076 | 1 | 4 | 22 |
GO:0030057 | desmosome | 3.06e-02 | 1.00e+00 | 5.011 | 1 | 1 | 23 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 3.06e-02 | 1.00e+00 | 5.011 | 1 | 2 | 23 |
GO:0043236 | laminin binding | 3.06e-02 | 1.00e+00 | 5.011 | 1 | 1 | 23 |
GO:0006513 | protein monoubiquitination | 3.06e-02 | 1.00e+00 | 5.011 | 1 | 1 | 23 |
GO:0043044 | ATP-dependent chromatin remodeling | 3.06e-02 | 1.00e+00 | 5.011 | 1 | 4 | 23 |
GO:0045879 | negative regulation of smoothened signaling pathway | 3.06e-02 | 1.00e+00 | 5.011 | 1 | 1 | 23 |
GO:0000722 | telomere maintenance via recombination | 3.45e-02 | 1.00e+00 | 4.835 | 1 | 7 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 3.45e-02 | 1.00e+00 | 4.835 | 1 | 2 | 26 |
GO:0000188 | inactivation of MAPK activity | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 1 | 27 |
GO:0048565 | digestive tract development | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 1 | 27 |
GO:0003823 | antigen binding | 3.71e-02 | 1.00e+00 | 4.728 | 1 | 1 | 28 |
GO:0010033 | response to organic substance | 3.71e-02 | 1.00e+00 | 4.728 | 1 | 2 | 28 |
GO:0043022 | ribosome binding | 3.71e-02 | 1.00e+00 | 4.728 | 1 | 3 | 28 |
GO:0031492 | nucleosomal DNA binding | 3.71e-02 | 1.00e+00 | 4.728 | 1 | 4 | 28 |
GO:0019894 | kinesin binding | 3.71e-02 | 1.00e+00 | 4.728 | 1 | 1 | 28 |
GO:0007067 | mitotic nuclear division | 3.83e-02 | 1.00e+00 | 2.683 | 2 | 13 | 231 |
GO:0019005 | SCF ubiquitin ligase complex | 3.84e-02 | 1.00e+00 | 4.677 | 1 | 1 | 29 |
GO:0003887 | DNA-directed DNA polymerase activity | 3.84e-02 | 1.00e+00 | 4.677 | 1 | 3 | 29 |
GO:0071897 | DNA biosynthetic process | 3.84e-02 | 1.00e+00 | 4.677 | 1 | 2 | 29 |
GO:0005759 | mitochondrial matrix | 3.89e-02 | 1.00e+00 | 2.671 | 2 | 12 | 233 |
GO:0007346 | regulation of mitotic cell cycle | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 3 | 30 |
GO:0006271 | DNA strand elongation involved in DNA replication | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 9 | 31 |
GO:0007093 | mitotic cell cycle checkpoint | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 2 | 31 |
GO:0050661 | NADP binding | 4.23e-02 | 1.00e+00 | 4.535 | 1 | 1 | 32 |
GO:0051219 | phosphoprotein binding | 4.23e-02 | 1.00e+00 | 4.535 | 1 | 3 | 32 |
GO:0033572 | transferrin transport | 4.23e-02 | 1.00e+00 | 4.535 | 1 | 6 | 32 |
GO:0031072 | heat shock protein binding | 4.36e-02 | 1.00e+00 | 4.491 | 1 | 2 | 33 |
GO:0000413 | protein peptidyl-prolyl isomerization | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 1 | 34 |
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 1 | 34 |
GO:0005876 | spindle microtubule | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 3 | 34 |
GO:0004842 | ubiquitin-protein transferase activity | 4.61e-02 | 1.00e+00 | 2.535 | 2 | 4 | 256 |
GO:0034332 | adherens junction organization | 4.74e-02 | 1.00e+00 | 4.365 | 1 | 1 | 36 |
GO:0051402 | neuron apoptotic process | 4.74e-02 | 1.00e+00 | 4.365 | 1 | 2 | 36 |
GO:0001895 | retina homeostasis | 4.74e-02 | 1.00e+00 | 4.365 | 1 | 1 | 36 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 4.87e-02 | 1.00e+00 | 4.326 | 1 | 4 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 4.87e-02 | 1.00e+00 | 4.326 | 1 | 4 | 37 |
GO:0006281 | DNA repair | 4.87e-02 | 1.00e+00 | 2.491 | 2 | 22 | 264 |
GO:0051539 | 4 iron, 4 sulfur cluster binding | 4.87e-02 | 1.00e+00 | 4.326 | 1 | 3 | 37 |
GO:0070527 | platelet aggregation | 5.00e-02 | 1.00e+00 | 4.287 | 1 | 2 | 38 |
GO:0050681 | androgen receptor binding | 5.00e-02 | 1.00e+00 | 4.287 | 1 | 4 | 38 |
GO:0021766 | hippocampus development | 5.13e-02 | 1.00e+00 | 4.250 | 1 | 4 | 39 |
GO:0006284 | base-excision repair | 5.13e-02 | 1.00e+00 | 4.250 | 1 | 7 | 39 |
GO:0006096 | glycolytic process | 5.13e-02 | 1.00e+00 | 4.250 | 1 | 4 | 39 |
GO:0022627 | cytosolic small ribosomal subunit | 5.13e-02 | 1.00e+00 | 4.250 | 1 | 3 | 39 |
GO:0000781 | chromosome, telomeric region | 5.26e-02 | 1.00e+00 | 4.213 | 1 | 2 | 40 |
GO:0044822 | poly(A) RNA binding | 5.34e-02 | 1.00e+00 | 1.461 | 4 | 50 | 1078 |
GO:0030521 | androgen receptor signaling pathway | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 2 | 41 |
GO:0006418 | tRNA aminoacylation for protein translation | 5.51e-02 | 1.00e+00 | 4.143 | 1 | 5 | 42 |
GO:0004722 | protein serine/threonine phosphatase activity | 5.51e-02 | 1.00e+00 | 4.143 | 1 | 1 | 42 |
GO:0035914 | skeletal muscle cell differentiation | 5.51e-02 | 1.00e+00 | 4.143 | 1 | 1 | 42 |
GO:0030155 | regulation of cell adhesion | 5.51e-02 | 1.00e+00 | 4.143 | 1 | 3 | 42 |
GO:0014070 | response to organic cyclic compound | 5.64e-02 | 1.00e+00 | 4.109 | 1 | 3 | 43 |
GO:0043966 | histone H3 acetylation | 5.90e-02 | 1.00e+00 | 4.043 | 1 | 2 | 45 |
GO:0021762 | substantia nigra development | 6.02e-02 | 1.00e+00 | 4.011 | 1 | 1 | 46 |
GO:0001047 | core promoter binding | 6.02e-02 | 1.00e+00 | 4.011 | 1 | 2 | 46 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 6.02e-02 | 1.00e+00 | 4.011 | 1 | 8 | 46 |
GO:0016567 | protein ubiquitination | 6.07e-02 | 1.00e+00 | 2.311 | 2 | 5 | 299 |
GO:0005905 | coated pit | 6.66e-02 | 1.00e+00 | 3.863 | 1 | 2 | 51 |
GO:0040008 | regulation of growth | 6.66e-02 | 1.00e+00 | 3.863 | 1 | 3 | 51 |
GO:0003684 | damaged DNA binding | 6.66e-02 | 1.00e+00 | 3.863 | 1 | 11 | 51 |
GO:0000775 | chromosome, centromeric region | 6.78e-02 | 1.00e+00 | 3.835 | 1 | 2 | 52 |
GO:0003725 | double-stranded RNA binding | 7.04e-02 | 1.00e+00 | 3.780 | 1 | 6 | 54 |
GO:0019900 | kinase binding | 7.04e-02 | 1.00e+00 | 3.780 | 1 | 1 | 54 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 7.04e-02 | 1.00e+00 | 3.780 | 1 | 5 | 54 |
GO:0050680 | negative regulation of epithelial cell proliferation | 7.04e-02 | 1.00e+00 | 3.780 | 1 | 1 | 54 |
GO:0000932 | cytoplasmic mRNA processing body | 7.29e-02 | 1.00e+00 | 3.728 | 1 | 3 | 56 |
GO:0006879 | cellular iron ion homeostasis | 7.41e-02 | 1.00e+00 | 3.702 | 1 | 5 | 57 |
GO:0000724 | double-strand break repair via homologous recombination | 7.41e-02 | 1.00e+00 | 3.702 | 1 | 6 | 57 |
GO:0051087 | chaperone binding | 7.66e-02 | 1.00e+00 | 3.652 | 1 | 6 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 7.66e-02 | 1.00e+00 | 3.652 | 1 | 4 | 59 |
GO:0045216 | cell-cell junction organization | 7.66e-02 | 1.00e+00 | 3.652 | 1 | 2 | 59 |
GO:0000723 | telomere maintenance | 7.66e-02 | 1.00e+00 | 3.652 | 1 | 8 | 59 |
GO:0031966 | mitochondrial membrane | 7.66e-02 | 1.00e+00 | 3.652 | 1 | 1 | 59 |
GO:0006302 | double-strand break repair | 8.04e-02 | 1.00e+00 | 3.581 | 1 | 8 | 62 |
GO:0019903 | protein phosphatase binding | 8.16e-02 | 1.00e+00 | 3.558 | 1 | 4 | 63 |
GO:0007059 | chromosome segregation | 8.29e-02 | 1.00e+00 | 3.535 | 1 | 3 | 64 |
GO:0006469 | negative regulation of protein kinase activity | 8.41e-02 | 1.00e+00 | 3.513 | 1 | 2 | 65 |
GO:0001558 | regulation of cell growth | 8.53e-02 | 1.00e+00 | 3.491 | 1 | 4 | 66 |
GO:0006338 | chromatin remodeling | 8.78e-02 | 1.00e+00 | 3.448 | 1 | 4 | 68 |
GO:0006289 | nucleotide-excision repair | 8.90e-02 | 1.00e+00 | 3.426 | 1 | 12 | 69 |
GO:0003697 | single-stranded DNA binding | 8.90e-02 | 1.00e+00 | 3.426 | 1 | 9 | 69 |
GO:0034329 | cell junction assembly | 9.15e-02 | 1.00e+00 | 3.385 | 1 | 1 | 71 |
GO:0055037 | recycling endosome | 9.40e-02 | 1.00e+00 | 3.345 | 1 | 2 | 73 |
GO:0000785 | chromatin | 9.40e-02 | 1.00e+00 | 3.345 | 1 | 5 | 73 |
GO:0006767 | water-soluble vitamin metabolic process | 9.64e-02 | 1.00e+00 | 3.306 | 1 | 3 | 75 |
GO:0007265 | Ras protein signal transduction | 9.64e-02 | 1.00e+00 | 3.306 | 1 | 3 | 75 |
GO:0031175 | neuron projection development | 9.64e-02 | 1.00e+00 | 3.306 | 1 | 1 | 75 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 9.76e-02 | 1.00e+00 | 3.287 | 1 | 3 | 76 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 9.89e-02 | 1.00e+00 | 3.268 | 1 | 5 | 77 |
GO:0046982 | protein heterodimerization activity | 9.99e-02 | 1.00e+00 | 1.895 | 2 | 11 | 399 |
GO:0006766 | vitamin metabolic process | 1.00e-01 | 1.00e+00 | 3.250 | 1 | 3 | 78 |
GO:0071013 | catalytic step 2 spliceosome | 1.01e-01 | 1.00e+00 | 3.231 | 1 | 7 | 79 |
GO:0019083 | viral transcription | 1.04e-01 | 1.00e+00 | 3.195 | 1 | 8 | 81 |
GO:0047485 | protein N-terminus binding | 1.10e-01 | 1.00e+00 | 3.109 | 1 | 4 | 86 |
GO:0006898 | receptor-mediated endocytosis | 1.10e-01 | 1.00e+00 | 3.109 | 1 | 2 | 86 |
GO:0006415 | translational termination | 1.11e-01 | 1.00e+00 | 3.092 | 1 | 8 | 87 |
GO:0042470 | melanosome | 1.17e-01 | 1.00e+00 | 3.011 | 1 | 10 | 92 |
GO:0006928 | cellular component movement | 1.17e-01 | 1.00e+00 | 3.011 | 1 | 7 | 92 |
GO:0006414 | translational elongation | 1.18e-01 | 1.00e+00 | 2.996 | 1 | 11 | 93 |
GO:0005200 | structural constituent of cytoskeleton | 1.18e-01 | 1.00e+00 | 2.996 | 1 | 7 | 93 |
GO:0071456 | cellular response to hypoxia | 1.24e-01 | 1.00e+00 | 2.920 | 1 | 4 | 98 |
GO:0006470 | protein dephosphorylation | 1.25e-01 | 1.00e+00 | 2.906 | 1 | 1 | 99 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.31e-01 | 1.00e+00 | 2.835 | 1 | 8 | 104 |
GO:0014069 | postsynaptic density | 1.34e-01 | 1.00e+00 | 2.807 | 1 | 1 | 106 |
GO:0016023 | cytoplasmic membrane-bounded vesicle | 1.35e-01 | 1.00e+00 | 2.794 | 1 | 3 | 107 |
GO:0042127 | regulation of cell proliferation | 1.39e-01 | 1.00e+00 | 2.741 | 1 | 4 | 111 |
GO:0006461 | protein complex assembly | 1.39e-01 | 1.00e+00 | 2.741 | 1 | 6 | 111 |
GO:0042802 | identical protein binding | 1.41e-01 | 1.00e+00 | 1.595 | 2 | 18 | 491 |
GO:0030308 | negative regulation of cell growth | 1.42e-01 | 1.00e+00 | 2.715 | 1 | 6 | 113 |
GO:0030529 | ribonucleoprotein complex | 1.43e-01 | 1.00e+00 | 2.702 | 1 | 8 | 114 |
GO:0044267 | cellular protein metabolic process | 1.43e-01 | 1.00e+00 | 1.584 | 2 | 24 | 495 |
GO:0019058 | viral life cycle | 1.44e-01 | 1.00e+00 | 2.690 | 1 | 10 | 115 |
GO:0006325 | chromatin organization | 1.53e-01 | 1.00e+00 | 2.592 | 1 | 4 | 123 |
GO:0007219 | Notch signaling pathway | 1.56e-01 | 1.00e+00 | 2.569 | 1 | 4 | 125 |
GO:0006260 | DNA replication | 1.56e-01 | 1.00e+00 | 2.569 | 1 | 12 | 125 |
GO:0007050 | cell cycle arrest | 1.57e-01 | 1.00e+00 | 2.558 | 1 | 7 | 126 |
GO:0005506 | iron ion binding | 1.58e-01 | 1.00e+00 | 2.546 | 1 | 3 | 127 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.58e-01 | 1.00e+00 | 2.546 | 1 | 5 | 127 |
GO:0006413 | translational initiation | 1.63e-01 | 1.00e+00 | 2.502 | 1 | 12 | 131 |
GO:0009615 | response to virus | 1.64e-01 | 1.00e+00 | 2.491 | 1 | 6 | 132 |
GO:0000790 | nuclear chromatin | 1.65e-01 | 1.00e+00 | 2.480 | 1 | 7 | 133 |
GO:0031982 | vesicle | 1.66e-01 | 1.00e+00 | 2.469 | 1 | 10 | 134 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.69e-01 | 1.00e+00 | 2.437 | 1 | 7 | 137 |
GO:0003735 | structural constituent of ribosome | 1.74e-01 | 1.00e+00 | 2.395 | 1 | 8 | 141 |
GO:0061024 | membrane organization | 1.79e-01 | 1.00e+00 | 2.345 | 1 | 5 | 146 |
GO:0010008 | endosome membrane | 1.92e-01 | 1.00e+00 | 2.240 | 1 | 6 | 157 |
GO:0006974 | cellular response to DNA damage stimulus | 1.93e-01 | 1.00e+00 | 2.231 | 1 | 8 | 158 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 1.94e-01 | 1.00e+00 | 2.222 | 1 | 4 | 159 |
GO:0000398 | mRNA splicing, via spliceosome | 2.00e-01 | 1.00e+00 | 2.169 | 1 | 12 | 165 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 2.04e-01 | 1.00e+00 | 2.143 | 1 | 5 | 168 |
GO:0030424 | axon | 2.08e-01 | 1.00e+00 | 2.109 | 1 | 3 | 172 |
GO:0005768 | endosome | 2.10e-01 | 1.00e+00 | 2.092 | 1 | 5 | 174 |
GO:0009897 | external side of plasma membrane | 2.20e-01 | 1.00e+00 | 2.019 | 1 | 4 | 183 |
GO:0015629 | actin cytoskeleton | 2.20e-01 | 1.00e+00 | 2.019 | 1 | 5 | 183 |
GO:0032403 | protein complex binding | 2.22e-01 | 1.00e+00 | 2.004 | 1 | 7 | 185 |
GO:0005765 | lysosomal membrane | 2.56e-01 | 1.00e+00 | 1.767 | 1 | 5 | 218 |
GO:0008380 | RNA splicing | 2.70e-01 | 1.00e+00 | 1.677 | 1 | 13 | 232 |
GO:0006412 | translation | 2.73e-01 | 1.00e+00 | 1.658 | 1 | 15 | 235 |
GO:0005524 | ATP binding | 2.74e-01 | 1.00e+00 | 0.717 | 3 | 46 | 1354 |
GO:0003713 | transcription coactivator activity | 2.77e-01 | 1.00e+00 | 1.634 | 1 | 10 | 239 |
GO:0008134 | transcription factor binding | 2.84e-01 | 1.00e+00 | 1.592 | 1 | 8 | 246 |
GO:0000166 | nucleotide binding | 3.09e-01 | 1.00e+00 | 1.448 | 1 | 6 | 272 |
GO:0005975 | carbohydrate metabolic process | 3.11e-01 | 1.00e+00 | 1.437 | 1 | 5 | 274 |
GO:0019899 | enzyme binding | 3.24e-01 | 1.00e+00 | 1.365 | 1 | 11 | 288 |
GO:0043234 | protein complex | 3.35e-01 | 1.00e+00 | 1.306 | 1 | 17 | 300 |
GO:0005856 | cytoskeleton | 3.45e-01 | 1.00e+00 | 1.254 | 1 | 8 | 311 |
GO:0019901 | protein kinase binding | 3.53e-01 | 1.00e+00 | 1.213 | 1 | 21 | 320 |
GO:0007411 | axon guidance | 3.60e-01 | 1.00e+00 | 1.182 | 1 | 9 | 327 |
GO:0008283 | cell proliferation | 3.63e-01 | 1.00e+00 | 1.164 | 1 | 12 | 331 |
GO:0043231 | intracellular membrane-bounded organelle | 3.64e-01 | 1.00e+00 | 1.160 | 1 | 8 | 332 |
GO:0005813 | centrosome | 3.70e-01 | 1.00e+00 | 1.130 | 1 | 12 | 339 |
GO:0003723 | RNA binding | 3.84e-01 | 1.00e+00 | 1.063 | 1 | 19 | 355 |
GO:0043565 | sequence-specific DNA binding | 3.92e-01 | 1.00e+00 | 1.023 | 1 | 4 | 365 |
GO:0005925 | focal adhesion | 3.96e-01 | 1.00e+00 | 1.004 | 1 | 18 | 370 |
GO:0005615 | extracellular space | 3.99e-01 | 1.00e+00 | 0.555 | 2 | 17 | 1010 |
GO:0005730 | nucleolus | 4.00e-01 | 1.00e+00 | 0.402 | 3 | 70 | 1684 |
GO:0007155 | cell adhesion | 4.08e-01 | 1.00e+00 | 0.950 | 1 | 8 | 384 |
GO:0009986 | cell surface | 4.38e-01 | 1.00e+00 | 0.814 | 1 | 9 | 422 |
GO:0045892 | negative regulation of transcription, DNA-templated | 4.40e-01 | 1.00e+00 | 0.807 | 1 | 14 | 424 |
GO:0006355 | regulation of transcription, DNA-templated | 4.44e-01 | 1.00e+00 | 0.426 | 2 | 17 | 1104 |
GO:0007596 | blood coagulation | 4.70e-01 | 1.00e+00 | 0.677 | 1 | 14 | 464 |
GO:0055114 | oxidation-reduction process | 4.82e-01 | 1.00e+00 | 0.625 | 1 | 11 | 481 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.87e-01 | 1.00e+00 | 0.607 | 1 | 17 | 487 |
GO:0055085 | transmembrane transport | 5.06e-01 | 1.00e+00 | 0.529 | 1 | 8 | 514 |
GO:0048471 | perinuclear region of cytoplasm | 5.12e-01 | 1.00e+00 | 0.504 | 1 | 12 | 523 |
GO:0045087 | innate immune response | 5.71e-01 | 1.00e+00 | 0.268 | 1 | 20 | 616 |
GO:0005794 | Golgi apparatus | 5.91e-01 | 1.00e+00 | 0.191 | 1 | 14 | 650 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 6.44e-01 | 1.00e+00 | -0.012 | 1 | 11 | 748 |
GO:0005737 | cytoplasm | 6.51e-01 | 1.00e+00 | -0.100 | 5 | 98 | 3976 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 6.74e-01 | 1.00e+00 | -0.129 | 1 | 19 | 811 |
GO:0005887 | integral component of plasma membrane | 7.37e-01 | 1.00e+00 | -0.373 | 1 | 7 | 961 |
GO:0005576 | extracellular region | 7.68e-01 | 1.00e+00 | -0.500 | 1 | 9 | 1049 |
GO:0008270 | zinc ion binding | 7.74e-01 | 1.00e+00 | -0.524 | 1 | 12 | 1067 |
GO:0003677 | DNA binding | 8.51e-01 | 1.00e+00 | -0.865 | 1 | 26 | 1351 |
GO:0046872 | metal ion binding | 8.74e-01 | 1.00e+00 | -0.982 | 1 | 24 | 1465 |
GO:0006351 | transcription, DNA-templated | 8.94e-01 | 1.00e+00 | -1.095 | 1 | 25 | 1585 |
GO:0005886 | plasma membrane | 9.15e-01 | 1.00e+00 | -0.934 | 2 | 38 | 2834 |